Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # 2015001032) on 17-DEC-2015. Case received from a physician via health authority on 15-DEC-2015 under reference number DK-DKMA-WBS-0002035. A 14-year-old female adolescent patient received GARDASIL, (batch number unknown, Dose 1) via intramuscular route in Mar-2009, GARDASIL, (batch number unknown, Dose 2) via intramuscular route in May-2009, GARDASIL, (batch number unknown, Dose 3) via intramuscular route in Sep-2009. The patient experienced Headache (except migraine) aggravated in SEP-2009, Vascular abnormalities on an unknown date, Dizziness on an unknown date, Nausea on an unknown date, Abdominal pain on an unknown date, Acne on an unknown date, Fatigue on an unknown date, Cognitive disorder on an unknown date, Limb weakness on an unknown date, Sound sensitivity on an unknown date and cold hands and feets on an unknown date. Patient reports that she first developed aggravated headache (already had headaches after prev. concussion), thereafter she developed cold hands and feet. The departments investigations shows that she does not fulfill the diagnostic criteria for POTS., but she has a significant initial hypertension. Other medicines or vaccines: unknown. The patient had a medical history of: Headache -Concussion. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166